GQ style: a multipronged therapeutic approach to pulmonary arterial hypertension.
作者信息
Kuebler Wolfgang M
机构信息
Institute of Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
出版信息
Pflugers Arch. 2025 Jan;477(1):31-33. doi: 10.1007/s00424-024-03056-2. Epub 2024 Dec 17.
Abstract
摘要
相似文献
1
GQ style: a multipronged therapeutic approach to pulmonary arterial hypertension.
Pflugers Arch. 2025 Jan;477(1):31-33. doi: 10.1007/s00424-024-03056-2. Epub 2024 Dec 17.
2
Pharmacological Gq inhibition induces strong pulmonary vasorelaxation and reverses pulmonary hypertension.
EMBO Mol Med. 2024 Aug;16(8):1930-1956. doi: 10.1038/s44321-024-00096-0. Epub 2024 Jul 8.
3
Critical Care Management of the Patient with Pulmonary Hypertension.
Clin Chest Med. 2021 Mar;42(1):155-165. doi: 10.1016/j.ccm.2020.11.009.
4
Gq-coupled receptor agonists mediate cardiac hypertrophy via the vasculature.
Hypertension. 2002 Nov;40(5):660-6. doi: 10.1161/01.hyp.0000035397.73223.ce.
5
Combined treatment of large hepatocellular carcinoma with transcatheter arterial chemoembolization and percutaneous ethanol injection with a multipronged needle: experimental and clinical investigation.
Cardiovasc Intervent Radiol. 2012 Apr;35(2):325-33. doi: 10.1007/s00270-011-0184-0. Epub 2011 May 24.
6
[Pulmonary arterial hypertension (PAH ) : a new era of pulmonary arterial vasodilatators].
Rev Med Liege. 2020 May;75(5-6):344-349.
7
Pulmonary arterial hypertension in children: a medical update.
Curr Opin Pediatr. 2008 Jun;20(3):288-93. doi: 10.1097/MOP.0b013e3282ff5fdc.
8
An evidence-based approach to the management of pulmonary arterial hypertension.
Curr Opin Cardiol. 2006 Jul;21(4):385-92. doi: 10.1097/01.hco.0000231410.07426.9b.
9
Microvesicles-mediated Cell Communication in Pulmonary Arterial Hypertension.
Curr Med Chem. 2021;28(23):4731-4741. doi: 10.2174/0929867328666201124152406.
10
Inhibition of angiotensin II Gq signaling augments beta-adrenergic receptor mediated effects in a renal artery stenosis model of high blood pressure.
J Mol Cell Cardiol. 2009 Jan;46(1):100-7. doi: 10.1016/j.yjmcc.2008.09.708. Epub 2008 Sep 30.
本文引用的文献
1
Pharmacological Gq inhibition induces strong pulmonary vasorelaxation and reverses pulmonary hypertension.
EMBO Mol Med. 2024 Aug;16(8):1930-1956. doi: 10.1038/s44321-024-00096-0. Epub 2024 Jul 8.
2
Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension.
Front Immunol. 2022 Jul 4;13:935787. doi: 10.3389/fimmu.2022.935787. eCollection 2022.
3
Perivascular Inflammation in Pulmonary Arterial Hypertension.
Cells. 2020 Oct 22;9(11):2338. doi: 10.3390/cells9112338.
4
Heterotrimeric G proteins as therapeutic targets?
J Biol Chem. 2020 Apr 17;295(16):5206-5215. doi: 10.1074/jbc.REV119.007061. Epub 2020 Mar 2.
5
The Role of the Human Immune System in Chronic Hypoxic Pulmonary Hypertension.
Am J Respir Crit Care Med. 2018 Aug 15;198(4):528-531. doi: 10.1164/rccm.201711-2175LE.
6
Interdicting Gq Activation in Airway Disease by Receptor-Dependent and Receptor-Independent Mechanisms.
Mol Pharmacol. 2016 Jan;89(1):94-104. doi: 10.1124/mol.115.100339. Epub 2015 Oct 13.
7
CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction.
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):E1614-23. doi: 10.1073/pnas.1421190112. Epub 2015 Mar 17.
8
Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
Am J Respir Crit Care Med. 2014 Oct 1;190(7):808-17. doi: 10.1164/rccm.201403-0442OC.
9
Diacylglycerol regulates acute hypoxic pulmonary vasoconstriction via TRPC6.
Respir Res. 2011 Feb 4;12(1):20. doi: 10.1186/1465-9921-12-20.
Zotero 插件